X0407 4 2023-06-13 0 0001744659 Akero Therapeutics, Inc. AKRO 0001778739 White William Richard C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer 1 Common Stock 2023-06-13 4 S 0 606 55.16 D 22377 D The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the reporting person. The sales reported on this Form 4 represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. Such sales were automatic and intended to qualify under Rule 10b5-1. /s/ Jonathan Young, Attorney-in-Fact 2023-06-15